Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002264712 | SCV002546364 | uncertain significance | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2022-07-07 | reviewed by expert panel | curation | This c.630A>G (p.Leu210=) synonymous variant is not predicted to have any splicing impact per SpliceAI (BP4), but it is located at a moderately conserved nucleotide per an evolutionary conservation prediction algorithm (PhyloP score = 2.5748 in GRCh38). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4. |
Labcorp Genetics |
RCV000537149 | SCV000638150 | likely benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004955627 | SCV005495300 | likely benign | Inborn genetic diseases | 2024-11-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |